In observance of Thanksgiving, We will be closed on Thursday, November 27th and Friday, November 28th. Keystone will resume normal business hours on Monday, December, 1st.

Reliable Urine Drug Test Labs Covered by Medicaid for You

As a clinical director, program manager, or billing coordinator at an outpatient care facility in central or western North Carolina, eastern Tennessee, or northern South Carolina, you need a reliable urine drug test lab covered by Medicaid to maintain compliance and ensure accurate patient monitoring in pain management clinics, MAT/Suboxone programs, and substance use recovery centers. Keystone Lab stands as your trusted regional partner, offering fast, accurate urine, oral swab, and blood toxicology testing with full Medicaid coverage.

Here’s what you need to know to leverage Medicaid-covered toxicology services and streamline your workflow while meeting regulatory standards.

Medicaid coverage overview

Eligibility and benefits

Medicaid covers toxicology testing when it is medically necessary for patient care, including:

Benefits of choosing a Medicaid-friendly lab partner include reduced out-of-pocket costs for your patients, simplified billing workflows, and minimized claim denials.

Covered testing types

Medicaid reimbursement typically extends to:

You can also compare Medicaid-approved options with other programs in our medicaid approved toxicology lab services resource.

Keystone Lab regional services

Service area and partnerships

Keystone Lab specializes in serving outpatient providers across central and western North Carolina, eastern Tennessee, and northern South Carolina. We partner with:

  • Pain management clinics seeking opioid adherence monitoring
  • MAT/Suboxone programs requiring regular compliance screens
  • Substance use recovery centers with stringent reporting requirements

We integrate seamlessly with electronic medical records and offer dedicated account management to simplify coordination between your facility and our lab.

Sample types offered

Keystone Lab provides:

  • Urine drug testing with rapid immunoassay screening and confirmatory analysis
  • Oral fluid testing for streamlined, observed collection
  • Blood toxicology panels for high-complexity cases

All specimens are processed under CLIA oversight, and results are delivered via secure online portal or direct EMR interface.

Exploring testing methods

Presumptive testing

Presumptive, or screening, tests use immunoassays to detect drug classes quickly. Key features:

  • Fast turnaround (often same day)
  • Cost-effective for routine monitoring
  • May yield false positives requiring confirmation

Definitive testing

Definitive tests confirm and quantify specific drugs or metabolites using chromatography-mass spectrometry.

Testing type Method Purpose Typical turnaround
Presumptive Immunoassay Initial screen Same day
Definitive GC-MS / LC-MS/MS Confirmatory analysis 24–48 hours

GC-MS

Gas Chromatography-Mass Spectrometry separates volatiles via a gaseous mobile phase then analyzes fragments by mass spectrometry. It reliably identifies specific drugs and metabolites down to nanogram levels (CMS).

LC-MS/MS

Liquid Chromatography-Tandem Mass Spectrometry uses a liquid mobile phase for nonvolatile or thermally unstable compounds, offering high sensitivity and specificity for a wide array of substances (CMS).

Ensuring compliance standards

CLIA certification levels

Under the Clinical Laboratory Improvement Amendments, labs must obtain CLIA certification based on testing complexity:

  • CLIA-waived: simple tests with minimal risk
  • Moderate complexity: includes many immunoassays
  • High complexity: chromatography-mass spectrometry methods (CMS)

Keystone Lab holds high-complexity certification to perform both screening and confirmatory assays.

Risk assessment protocols

You should base testing decisions on each patient’s clinical presentation, prescribed medications, and risk profile. Risk assessments are a widely accepted standard in clinical treatment and follow-up (CMS).

Testing frequency guidelines

Frequency of urine drug testing for chronic opioid therapy is stratified by risk level:

  • High risk: up to 3 presumptive and 3 definitive tests per 90 days
  • Moderate risk: individualized based on clinical judgment
  • Low risk: no more than 2 tests per 365 days (CMS)

Adhering to these guidelines ensures you remain compliant with Medicaid coverage policies and maintain best practices in patient safety.

Choosing your lab partner

Key selection criteria

When evaluating a Medicaid-friendly urine drug test lab, consider:

  • Accreditation and CLIA certification
  • Range of testing methods (immunoassay, GC-MS, LC-MS/MS)
  • Turnaround times and result delivery options
  • Integration with your electronic medical record system
  • Regional experience and dedicated account support

Insurance and billing support

A comprehensive lab partner simplifies billing and reduces administrative burden. Keystone Lab:

  • Accepts Medicaid as well as commercial payers
  • Offers transparent pricing and pre-authorization assistance
  • Provides electronic claim submission and real-time eligibility checks

If you also handle suboxone compliance or MAT programs, you may review toxicology testing for suboxone clinics and urine drug screening for mat programs for specialized offerings.

Next steps with Keystone

Ordering tests

  1. Enroll your facility via our secure online portal
  2. Select required test panels and frequency based on patient risk
  3. Ship specimens using our pre-paid FedEx labels or schedule pickup

Contact and logistics

  • Phone: (800) 555-KEYS
  • Email: support@keystonelab.com
  • Portal: portal.keystonelab.com

Keystone Lab is committed to supporting your outpatient facility with reliable, Medicaid-covered urine drug testing and comprehensive toxicology services. Reach out today to streamline your compliance processes and ensure the highest standard of patient care.

4th of July Closure Notice

In observance of Independence Day on July 4th, Keystone will be closed. Normal office hours will resume on the 5th of July.